tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Laaman, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).
Analyst Sean Laaman works at MORGAN STANLEY with a stock forecast success ratio of 80% fulfilled within 60 days on average.
Sean Laaman’s has documented 11 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 25-Jan-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 6/17/2020. The price target of $176 was fulfilled within 6 days with a profit of $8.86 (5.3%) receiving and performance score of 8.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
224
$36.24 (19.30%)
215
17 days ago
5/7 (71.43%)
$34.68 (18.32%)
371
Buy
215
$27.24 (14.51%)
215
22 days ago
7/11 (63.64%)
$18.67 (9.51%)
66
Buy
205
$17.24 (9.18%)
185
2 months 19 days ago
5/11 (45.45%)
$14.1 (7.39%)
88
164
$-23.76 (-12.65%)
158
2 months 24 days ago
4/6 (66.67%)
$-21.88 (-11.77%)
30
Buy
207
$19.24 (10.25%)
2 months 24 days ago
4/5 (80%)
$21.12 (11.36%)
60
Which stock is Sean Laaman is most bullish on?
What Year was the first public recommendation made by Sean Laaman?
